quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:02:18·43d
INSIDERFiling
Edesa Biotech Inc. logo

SEC Form 4 filed by Edesa Biotech Inc.

EDSA· Edesa Biotech Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • EDSA
    Edesa Biotech Inc.
    Health Care

Recent analyst ratings

  • Dec 20UpdateHC Wainwright & Co.$16.00

Related

  • INSIDER13d
    SEC Form 4 filed by Nijhawan Pardeep
  • SEC20d
    SEC Form DEFA14A filed by Edesa Biotech Inc.
  • SEC20d
    SEC Form DEF 14A filed by Edesa Biotech Inc.
  • PR23d
    Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
  • PR29d
    Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
  • SEC38d
    SEC Form SCHEDULE 13G filed by Edesa Biotech Inc.
  • INSIDER44d
    Chief Executive Officer Nijhawan Pardeep bought $6,599 worth of shares (1,000 units at $6.60), increasing direct ownership by 0.16% to 628,813 units (SEC Form 4)
  • INSIDER48d
    Chief Executive Officer Nijhawan Pardeep bought $39,000 worth of shares (10,000 units at $3.90) (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022